ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

QURE uniQure NV

4.81
0.13 (2.78%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
uniQure NV QURE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.13 2.78% 4.81 07:41:32
개장가 저가 고가 종가 전일 종가
4.78 4.66 4.965 4.69 4.68
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
06/03/202407:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202406:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202422:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/02/202422:00EDGAR2Form 8-K - Current report
28/02/202421:05GLOBEuniQure Announces 2023 Financial Results and Highlights..
27/02/202406:46EDGAR2Form 144 - Report of proposed sale of securities
27/02/202406:25EDGAR2Form 144 - Report of proposed sale of securities
14/02/202406:33EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/12/202321:12EDGAR2Form 8-K - Current report
19/12/202321:05GLOBEuniQure Announces Update on Phase I/II Clinical Trials of..
12/12/202309:30PRNUSCSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb)..
08/12/202321:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing..
29/11/202321:05GLOBEuniQure Announces FDA Clearance of Investigational New Drug..
17/11/202320:00EDGAR2Form 8-K - Current report
07/11/202321:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:31EDGAR2Form 8-K - Current report
07/11/202321:05GLOBEuniQure Announces Third Quarter 2023 Financial Results and..
27/10/202323:00PRNUSCSL and uniQure Win 2023 Prix Galien USA Award
27/10/202303:38PRNCASanté Canada autorise HEMGENIX® de CSL (étranacogène..
27/10/202303:14PRNCAHealth Canada Authorizes CSL's HEMGENIX® (etranacogene..
24/10/202320:05GLOBEuniQure Announces Major Presence at the European Society of..
06/10/202319:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/10/202319:32EDGAR2Form DEF 14A - Other definitive proxy statements
06/10/202305:32EDGAR2Form 8-K - Current report
05/10/202320:05GLOBEuniQure Announces Strategic Reorganization to Reduce..
03/10/202310:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202320:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing..
21/09/202305:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202302:59DJNRe/Max, UniQure and Trinseo Fall to 52-Week Lows on Exit..
05/09/202320:05GLOBEuniQure Announces FDA Clearance of Investigational New Drug..
02/09/202307:51PRNUSBlackstone and Airbnb Set to Join S&P 500; Others to Join..
02/08/202305:30EDGAR2Form 8-K - Current report
01/08/202320:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/08/202320:05GLOBEuniQure Announces Second Quarter 2023 Financial Results and..
13/07/202305:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/07/202323:58EDGAR2Form 144 - Report of proposed sale of securities
26/06/202320:11GLOBEuniQure Announces Leadership Addition to Support Advancement..
21/06/202320:05GLOBEuniQure Announces Update on U.S. Phase I/II Clinical Trial..
20/06/202320:05GLOBEuniQure announces achievement of $100 million..
20/06/202320:00PRNUSCSL Behring Announces the First Patient Has Received..
16/06/202320:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing..
15/05/202320:05GLOBEuniQure Announces Sale of Royalty Interest in HEMGENIX® for..
09/05/202320:05GLOBEuniQure Announces First Quarter 2023 Financial Results and..

최근 히스토리

Delayed Upgrade Clock